PAMS
CCXI
Pictet Asset Management (Switzerland)’s ChemoCentryx, Inc. CCXI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,900
| Closed | -$201K | – | 2022 |
|
|
2022
Q3 | $201K | Sell |
3,900
-2,368,745
| -100% | -$122M | ﹤0.01% | 1411 |
|
|
2022
Q2 | $58.8M | Buy |
2,372,645
+532,478
| +29% | +$13.2M | 0.08% | 257 |
|
|
2022
Q1 | $46.1M | Buy |
1,840,167
+234,758
| +15% | +$5.89M | 0.05% | 326 |
|
|
2021
Q4 | $58.5M | Buy |
+1,605,409
| New | +$58.5M | 0.06% | 317 |
|